Первая клетка. И чего стоит борьба с раком до последнего

Bister K. Discovery of Oncogenes: The Advent of Molecular Cancer Research. PNAS. 112, no. 50 (2015): 15259–15260.

Lane D., Levine A. P53 Research: The Past 30 Years and the Next 30 Years. Cold Spring Harbor Perspectives in Biology. 2, no. 12 (2010): a000893.

Donehower L. A. Using Mice to Examine p53 Functions in Cancer, Aging, and Longevity. Cold Spring Harbor Perspectives in Biology. 1, no. 6 (2009): a001081.

Lane D. P. et al. P53-Based Cancer Therapy. Cold Spring Harbor Perspectives in Biology. 2, no. 9 (2010): a001222.

Bieging K. T. et al. Unravelling Mechanisms of p53-Mediated Tumour Suppression. Nature Reviews Cancer. 14 (2014): 359–370.

Li F. P., Fraumeni J. F. Soft-Tissue Sarcomas, Breast Cancer, and Other Neoplasms: A Familial Syndrome? Annals of Internal Medicine. 71, no. 4 (1969): 747–752.

Hisada M. et al. Multiple Primary Cancers in Families with Li-Fraumeni Syndrome. Journal of the National Cancer Institute. 90, no. 8 (1998): 606–611.

Birch J. M. et al. Prevalence and Diversity of Constitutional Mutations in the p53 Gene Among 21 Li-Fraumeni Families. Cancer Research. 54, no. 5 (1994): 1298–1304.

Greicius J. And Yet, You Try: A Father’s Quest to Save His Son. Stanford Medicine: Diagnostics, Fall 2016. https://stanmed.stanford.edu/2016fall/milan-gambhirs-li-fraumeni-syndrome.html

Haase D. TP53 Mutation Status Divides Myelodysplastic Syndromes with Complex Karyotypes into Distinct Prognostic Subgroups. Nature, January 2019. doi:10.1038/s41375-018-0351-2.

Martinez-Hoyer S. et al. Mechanisms of Resistance to Lenalidomide in Del(5q) Myelodysplastic Syndrome Patients. Blood. 126 (2015): 5228.

Abegglen L. M. et al. Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage in Humans. JAMA. 314, no. 17 (2015): 1850–1860.

Caulin A. F., Maley C. C. Peto’s Paradox: Evolution’s Prescription for Cancer Prevention. Trends in Ecology & Evolution. 26, no. 4 (2011): 175–182.

Tollis M. et al. Paradox: How Has Evolution Solved the Problem of Cancer Prevention? BMC Biology. 15, no. 60 (2017).

Callaway E. How Elephants Avoid Cancer: Pachyderms Have Extra Copies of a Key Tumour-Fighting Gene. Nature, October 8, 2015. doi:10.1038/nature.2015.18534.

Armstrong S. P53: The Gene That Cracked the Cancer Code. New York: Bloomsbury Sigma, 2016.

GarcÍa-Cao I. “Super p53” Mice Exhibit Enhanced DNA Damage Response, Are Tumor Resistant and Age Normally. EMBO Journal. 21, no. 22 (2002): 6225–6235.

Hogenboom M. The Animal That Don’t Get Cancer. BBC, October 31, 2015. www.bbc.com/earth/story/20151031-the-animal-that-doesnt-get-cancer

Tomasetti C. et al. Stem Cell Divisions, Somatic Mutations, Cancer Etiology, and Cancer Prevention. Science. 355, no. 331 (2017): 1330–1334.

Vogelstein B. et al. Cancer Genome Landscapes. Science. 339, no. 6127 (2013): 1546–1558.

New Study Finds That Most Cancer Mutations Are Due to Random DNA Copying ‘Mistakes’. Johns Hopkins Medicine, March 23, 2017. www.hopkinsmedicine.org/news/media/releases/new_study_finds_that_most_cancer_mutations_are_due_to_random_dna_copying_mistakes

Yachida S. et al. Distant Metastasis Occurs Late During the Genetic Evolution of Pancreatic Cancer. Nature. 467 (2010): 1114–1117.